SLC7A11 and neoplasm: For example, cancer immunotherapy has been shown to enhance the effector function of CD8+ T cells, increase IFNγ release to downregulate SLC3A2 and SLC7A11 expression, resulting in reduced cystine uptake and increased ferroptosis in tumor cells (Wang et al., 2019).